DE69333396D1 - Einschlusskomplex von Taxol, Verfahren zu seiner Herstellung und Verwendung - Google Patents

Einschlusskomplex von Taxol, Verfahren zu seiner Herstellung und Verwendung

Info

Publication number
DE69333396D1
DE69333396D1 DE69333396T DE69333396T DE69333396D1 DE 69333396 D1 DE69333396 D1 DE 69333396D1 DE 69333396 T DE69333396 T DE 69333396T DE 69333396 T DE69333396 T DE 69333396T DE 69333396 D1 DE69333396 D1 DE 69333396D1
Authority
DE
Germany
Prior art keywords
taxol
preparation
inclusion complex
inclusion
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69333396T
Other languages
English (en)
Other versions
DE69333396T2 (de
Inventor
C O Ensuiko Sugar Refin Mikuni
C O Ensuiko Sugar Ref Kuwahara
C O Okayamarika-Daigaku Hamada
C O Okayamarika-Daigaku Saito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ensuiko Sugar Refining Co Ltd
Original Assignee
Ensuiko Sugar Refining Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ensuiko Sugar Refining Co Ltd filed Critical Ensuiko Sugar Refining Co Ltd
Publication of DE69333396D1 publication Critical patent/DE69333396D1/de
Application granted granted Critical
Publication of DE69333396T2 publication Critical patent/DE69333396T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
DE69333396T 1992-11-27 1993-03-30 Einschlusskomplex von Taxol mit Cyclodextrin, Verfahren zu seiner Herstellung und Verwendung Expired - Fee Related DE69333396T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4339495A JPH06157330A (ja) 1992-11-27 1992-11-27 タキソールのサイクロデキストリン包接物，その製造法と用途

Publications (2)

Publication Number Publication Date
DE69333396D1 true DE69333396D1 (de) 2004-02-26
DE69333396T2 DE69333396T2 (de) 2004-10-21

Family

ID=18328013

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69333396T Expired - Fee Related DE69333396T2 (de) 1992-11-27 1993-03-30 Einschlusskomplex von Taxol mit Cyclodextrin, Verfahren zu seiner Herstellung und Verwendung

Country Status (7)

Country Link
EP (1) EP0605753B1 (de)
JP (1) JPH06157330A (de)
AU (1) AU645927B1 (de)
CA (1) CA2092979C (de)
DE (1) DE69333396T2 (de)
DK (1) DK0605753T3 (de)
HU (1) HU212582B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602112A (en) * 1992-06-19 1997-02-11 Supergen, Inc. Pharmaceutical formulation
JPH0753396A (ja) * 1993-08-19 1995-02-28 Ensuiko Sugar Refining Co Ltd タキソールのサイクロデキストリン包接物，その製造法および用途
HU213200B (en) * 1993-05-12 1997-03-28 Chinoin Gyogyszer Es Vegyeszet The cyclodextrin or cyclodextrin derivative cluster complexes of taxol, taxotere, or taxus, pharmaceutical preparations containing them and process for their production
FR2715307B1 (fr) * 1994-01-25 1996-04-05 Commissariat Energie Atomique Procédé de solubilisation dans un milieu aqueux d'agents antitumoraux de la famille du taxol, et cyclodextrines ramifiées utilisables pour cette solubilisation.
FR2716200B1 (fr) * 1994-02-11 1996-04-26 Commissariat Energie Atomique Procédé de préparation de cyclomaltooligosaccharides ramifiés, en particulier de cyclodextrines ramifiées.
HUT73844A (en) * 1994-11-11 1996-09-30 Chinoin Gyogyszer Es Vegyeszet New taxol complexes and pharmaceutical compositions containing them
FR2746103B1 (fr) * 1996-03-14 1998-07-24 Thioureido-cyclodextrines, utilisables en particulier pour solubiliser des agents antitumoraux et antiparasitaires et leurs procedes de preparation
HUP9701945A3 (en) * 1997-11-10 2000-04-28 Hexal Ag Pharmaceutical composition for injection containing cyclodextrin and taxoids
JP4585074B2 (ja) * 2000-03-28 2010-11-24 ライオン株式会社 薬剤組成物の製造方法
US6951885B2 (en) 2000-08-10 2005-10-04 Takeda Pharmaceutical Company Limited Pharmaceutical composition
JP4922507B2 (ja) * 2000-08-10 2012-04-25 武田薬品工業株式会社 医薬組成物
FR2852959B1 (fr) * 2003-03-28 2008-02-15 Centre Nat Rech Scient Nouveaux derives de cyclodextrines, leur procede de preparation et leur utilisation notamment pour solubilisation de substances pharmacologiquement actives
CN100486645C (zh) 2006-09-12 2009-05-13 南京师范大学 含有环糊精紫杉醇包合物的药物组合物及其制备方法
CN100411688C (zh) 2006-09-12 2008-08-20 南京师范大学 含有环糊精/多烯紫杉醇包合物的药物组合物及其制备方法
WO2010029575A2 (en) * 2008-08-18 2010-03-18 Vishwanath Kannan Docetaxel lyophilized parentaral formulation for safe drug delivery system and process of making thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU181703B (en) * 1980-05-09 1983-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents
GB8920135D0 (en) * 1989-09-06 1989-10-18 Erba Carlo Spa Use of dehydrated cyclodextrins for improving drug dissolution
WO1991004026A1 (en) * 1989-09-14 1991-04-04 Australian Commercial Research & Development Limited Drug delivery compositions
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
ATE196426T1 (de) * 1991-06-21 2000-10-15 Takeda Chemical Industries Ltd Zyklodextrin-zusammensetzung enthaltend fumagillol-derivate
FR2678833B1 (fr) * 1991-07-08 1995-04-07 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes.

Also Published As

Publication number Publication date
EP0605753A1 (de) 1994-07-13
HU9301166D0 (en) 1993-07-28
AU645927B1 (en) 1994-01-27
HUT65835A (en) 1994-07-28
HU212582B (en) 1996-08-29
CA2092979C (en) 2004-01-27
CA2092979A1 (en) 1994-05-28
JPH06157330A (ja) 1994-06-03
DE69333396T2 (de) 2004-10-21
DK0605753T3 (da) 2004-04-19
EP0605753B1 (de) 2004-01-21

Similar Documents

Publication Publication Date Title
DE69214306T2 (de) Organopentasiloxan und Verfahren zu seiner Herstellung
DE69029151T2 (de) Modifizierte Polyesterzusammensetzung, Verfahren zu deren Herstellung und deren Verwendung
DE59306172D1 (de) Flammenhydrolytisch hergestelltes Titandioxid-Mischoxid, Verfahren zu seiner Herstellung und Verwendung
DE69013416T2 (de) Wundverband und Verfahren zu seiner Herstellung.
DE68905448T2 (de) Siliziumpulver und Verfahren zu seiner Herstellung.
DE69207234T3 (de) Katalysatorkörper und Verfahren zu seiner Herstellung
DE69331176T2 (de) Knochenzement und Verfahren zu seiner Herstellung
DE69116599T3 (de) Polyisocyanatoisocyanurat, Verfahren zu seiner Herstellung und seine Verwendung
DE69025582T3 (de) Beschichteter Hartmetallkörper und Verfahren zu seiner Herstellung
DE599775T1 (de) Gelstiftantipersperantien und Verfahren zu seiner Herstellung.
DE69218125D1 (de) Katalysator und Verfahren zu seiner Herstellung
DE69333396D1 (de) Einschlusskomplex von Taxol, Verfahren zu seiner Herstellung und Verwendung
DE69216692D1 (de) Kondensator und Verfahren zu seiner Herstellung
DE69032447D1 (de) Thermistor und Verfahren zu seiner Herstellung
DE69002355T2 (de) Nahrungsmittel und Verfahren zu seiner Herstellung.
DE69301771T2 (de) T-Butyl-R-(-)-4-cyano-3-hydroxybutyrat und Verfahren zu seiner Herstellung
DE69419203D1 (de) Mikrowellenabsorber und Verfahren zu seiner Herstellung
DE69433156D1 (de) Varistor und Verfahren zu seiner Herstellung
DE59506347D1 (de) Zirkondioxidpulver, Verfahren zu seiner Herstellung und Verwendung
DE59307440D1 (de) Schamottestein und Verfahren zu seiner Herstellung
DE59007537D1 (de) Kondensator und Verfahren zu seiner Herstellung.
DE69016882D1 (de) Entwickler und Verfahren zu seiner Herstellung.
DE69310279D1 (de) Gleitfilm und Verfahren zu seiner Herstellung
DE59209489D1 (de) Verwendung von 1-Thiocarbamoyl 5-hydroxy-pyrazolen als Mikrobizide, 1-Thiocarbamoyl 5-hydroxy-pyrazole und Verfahren zu ihrer Herstellung
DE69010805D1 (de) Boriertes Gleitmaterial und Verfahren zu seiner Herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee